Fate Therapeutics Other Current Borrowings (Quarterly) Trends

Fate Therapeutics, Inc. (FATE)

1.61 -0.01 (-0.62%) USD | NASDAQ | Feb 25, 12:44

View Other Current Borrowings (Quarterly) for FATE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Current Borrowings (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Current Borrowings (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Current Borrowings (Quarterly) Benchmarks

Start Trial

MannKind Corp.	Upgrade
Vertex Pharmaceuticals, Inc.	--
Ardelyx, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	--